Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Revance Therapeutics Inc (NASDAQ:RVNC)

During the Trading Day
30.26 -0.24 / -0.79%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
30.26 0.00 / 0.00%
 
Volume: 2.4K
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close30.50
Today’s open30.47
Day’s range29.80 - 30.82
Volume70,461
Average volume (3 months)203,617
Market cap$730.5M
Dividend yield--
Data as of 3:59pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)-408.57%
Earnings growth (this year)-7.61%
Earnings growth (next 5 years)--
Revenue growth (last year)-37.93%
P/E ratioNM
Price/Sales857.68
Price/Book4.11

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc-0.38-2.22%
ENTAEnanta Pharmaceutica...-2.14-5.20%
TGTXTG Therapeutics Inc-0.74-5.68%
DERMDermira Inc-1.54-5.65%
Data as of 3:59pm ET, 08/31/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$1.00
Annual revenue (last year)$383.0K
Annual profit (last year)-$62.9M
Net profit margin-16,427.42%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
CFO &
Executive VP-Corporate Development
Lauren P. Silvernail
Corporate headquarters
Newark, California

Forecasts

Partner Offers